All outcomes have no statistically significant difference, excluding a marginally statistically significant increase in adverse events ≥ G3 with 5-fluorouracil.
← all excerpts
"Add More Arrows to Your Quiver": The Role of Adding Another Chemotherapy Drug to Fluoropyrimidine and Long Term Radiotherapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
1
—
—